LORI ABNEY: Open Payments
NPI 1053654509 · CAMPBELLSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 38 payments from 14 companies in 2025. Trend: 2023 $1,131 · 2024 $1,064 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $293 |
| ABBVIE INC. | 5 | $102 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Novo Nordisk Inc | 5 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
Products named: FARXIGA, CAPLYTA, TRELEGY ELLIPTA, Ozempic, VRAYLAR, AIRSUPRA, UBRELVY, Auvelity.
Industry payments across KY — which companies pay providers there.
